| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 1991 | 2018 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 2011 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2011 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.030 | None | 1.000 | 2 | 0 | 1991 | 2011 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1993 | 2018 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2016 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
phenotype | 0.100 | None | 0.929 | 14 | 0 | 1993 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 |